rs5030868

Variant summary

Our verdict is Pathogenic.
+10 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 10 classification points (ACMG Germline Pathogenicity v2019). PS3PP3_ModeratePP5_Strong

The NM_001360016.2(G6PD):c.563C>T (p.Ser188Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00141 (AC=1,705) in the gnomAD database across 1,209,752 control chromosomes, including 23 homozygotes and 859 hemizygotes. The grpmax filtering allele frequency (95% CI) is 0.0383. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000321681: Published functional studies demonstrate decreased enzyme activity in circulating erythrocytes, increased affinity for G6P, and decreased in vitro thermostability (Vulliamy et al., 1998);" and additional evidence is available in ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S188= (synonymous): Likely_benign (ClinVar VariationId 1107399, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.

Frequency

Genomes: 𝑓 0.00072 ( 2 hom., 37 hem., cov: 23)
Exomes 𝑓: 0.0015 ( 21 hom. 822 hem. )

Consequence

G6PD
NM_001360016.2 missense

Scores

6
7
3

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:62O:3

Conservation

PhyloP100: 5.54

Publications

246 publications found
Variant links:
Genes affected
G6PD (HGNC:4057): (glucose-6-phosphate dehydrogenase) This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
G6PD Gene-Disease associations (from GenCC):
  • anemia, nonspherocytic hemolytic, due to G6PD deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, PanelApp Australia
  • G6PD deficiency
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • class I glucose-6-phosphate dehydrogenase deficiency
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001360016.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 points.

PS3
Well-established functional study supports damaging effect (PS3); SCV000321681: Published functional studies demonstrate decreased enzyme activity in circulating erythrocytes, increased affinity for G6P, and decreased in vitro thermostability (Vulliamy et al., 1998);; SCV000885494: Functional analyses of the variant protein shows decreased enzyme activity, increased affinity for G6P and decreased in vitro thermostability (Moiz 2012, Molou 2014, Vulliamy 1988).; SCV000647802: Experimental studies have shown that this missense change affects G6PD function (PMID: 3393536, 22906047, 24460025).; SCV002073219: Experimental studies have shown that this missense change affects G6PD function (Molouet. al., 2014).; SCV002572646: Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 22906047, 24460025, 3393536).; SCV002599337: Decreased activity in red blood cells (0-33%) (PS3).; SCV003921882: "This variant has strong functional evidence supporting abnormal protein function. The variant has been shown to result in highly impaired enzyme activity (PMID: 3393536, PMID: 7211845)."; SCV006557123: Experimental studies support this variant is deleterious.; SCV000915299: The c.563C>T variant resulted in 0-7% residual enzyme activity in red blood cells compared to wild type and caused decreased thermostability and reduced catalytic activity (PMID: 3393536).; SCV004122524: The most pronounced variant effect results in <10% of normal activity (Vulliamy_1988).; SCV001443686: Functional studies demonstrate decreased enzyme activity in the circulating erythrocytes of individuals with this variant, increased affinity for G6P and decreased in vitro thermostability (PMID: 9342374, 3393536).
PP3
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate).
PP5
ClinVar 2-star pathogenic — strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s). ClinVar submissions strongly and reliably favor pathogenicity (64/64 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_001360016.2. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
G6PD
NM_001360016.2
MANE Select
c.563C>Tp.Ser188Phe
missense
Exon 6 of 13NP_001346945.1A0A384NL00
G6PD
NM_000402.4
c.653C>Tp.Ser218Phe
missense
Exon 6 of 13NP_000393.4P11413-3
G6PD
NM_001042351.3
c.563C>Tp.Ser188Phe
missense
Exon 6 of 13NP_001035810.1P11413-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
G6PD
ENST00000393562.10
TSL:1 MANE Select
c.563C>Tp.Ser188Phe
missense
Exon 6 of 13ENSP00000377192.3P11413-1
G6PD
ENST00000696421.1
c.563C>Tp.Ser188Phe
missense
Exon 6 of 13ENSP00000512616.1A0A8Q3SIS5
G6PD
ENST00000369620.6
TSL:5
c.563C>Tp.Ser188Phe
missense
Exon 6 of 13ENSP00000358633.2P11413-2

Frequencies

GnomAD3 genomes
AF:
0.000733
AC:
82
AN:
111798
Hom.:
2
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00604
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0153
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0126
Gnomad NFE
AF:
0.000208
Gnomad OTH
AF:
0.00468
GnomAD2 exomes
AF:
0.00255
AC:
468
AN:
183257
AF XY:
0.00375
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00601
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000770
Gnomad OTH exome
AF:
0.00574
GnomAD4 exome
AF:
0.00148
AC:
1624
AN:
1097898
Hom.:
21
Cov.:
32
AF XY:
0.00226
AC XY:
822
AN XY:
363276
show subpopulations
African (AFR)
AF:
0.000303
AC:
8
AN:
26401
American (AMR)
AF:
0.0000284
AC:
1
AN:
35192
Ashkenazi Jewish (ASJ)
AF:
0.00547
AC:
106
AN:
19381
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30205
South Asian (SAS)
AF:
0.0189
AC:
1021
AN:
54137
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40482
Middle Eastern (MID)
AF:
0.0435
AC:
180
AN:
4135
European-Non Finnish (NFE)
AF:
0.000189
AC:
159
AN:
841880
Other (OTH)
AF:
0.00323
AC:
149
AN:
46085
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
52
104
155
207
259
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000724
AC:
81
AN:
111854
Hom.:
2
Cov.:
23
AF XY:
0.00108
AC XY:
37
AN XY:
34102
show subpopulations
African (AFR)
AF:
0.000130
AC:
4
AN:
30815
American (AMR)
AF:
0.00
AC:
0
AN:
10658
Ashkenazi Jewish (ASJ)
AF:
0.00604
AC:
16
AN:
2649
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3528
South Asian (SAS)
AF:
0.0149
AC:
40
AN:
2677
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6162
Middle Eastern (MID)
AF:
0.0138
AC:
3
AN:
218
European-Non Finnish (NFE)
AF:
0.000208
AC:
11
AN:
52952
Other (OTH)
AF:
0.00462
AC:
7
AN:
1515
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00118
Hom.:
66
Bravo
AF:
0.000559
EpiCase
AF:
0.00147
EpiControl
AF:
0.00119

Local populations

Turkish Variome
AF:
0.00858
AC:
57
AN:
6642
Hom.:
18
ABraOM SABE-WGS-1171
AF:
0.00104
AC:
2
AN:
1916
Hom.:
0

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
33
-
-
Anemia, nonspherocytic hemolytic, due to G6PD deficiency (33)
14
-
-
not provided (14)
5
-
-
G6PD deficiency (5)
2
-
-
Malaria, susceptibility to (2)
2
-
-
Malaria, susceptibility to;C2720289:Anemia, nonspherocytic hemolytic, due to G6PD deficiency (2)
1
-
-
G6PD deficient hemolytic anemia (1)
1
-
-
G6PD-related disorder (1)
1
-
-
Granulomatous disease, chronic, X-linked (1)
1
-
-
Hemolytic anemia, G6PD deficient (favism) (1)
1
-
-
Inborn genetic diseases (1)
1
-
-
See cases (1)
-
-
-
G6PD CAGLIARI (1)
-
-
-
G6PD MEDITERRANEAN (1)
-
-
-
G6PD SASSARI (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.45
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.96
D
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.95
D
MetaRNN
Benign
0.012
T
MetaSVM
Pathogenic
0.96
D
MutationAssessor
Pathogenic
3.4
M
PhyloP100
5.5
PrimateAI
Benign
0.36
T
PROVEAN
Uncertain
-4.2
D
REVEL
Pathogenic
0.81
Sift
Uncertain
0.017
D
Sift4G
Uncertain
0.0080
D
Varity_R
0.90
gMVP
0.93
Mutation Taster
=16/84
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5030868;
hg19: chrX-153762634;
COSMIC: COSV63704212;
COSMIC: COSV63704212;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.